Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Significance: Recently it has been suggested that metformin, the most commonly used antidiabetic drug, might also possess general health-promoting properties. Elucidating metformin’s mode of action will vastly increase its application range and will contribute to healthy aging. We reveal a signaling cascade in which metformin is able to extend lifespan by increasing the production of reactive oxygen species (ROS). This allowed us to further work at the crossroads of human disease and aging research, identifying a key molecule that is able to translate the ROS signal into a prolongevity cue: an antioxidant peroxiredoxin is also able to activate a lifespan-promoting signaling cascade, here described in detail. Continued research efforts in this field lead toward a targeted improvement of aging-related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice and C. elegans, metformin extends lifespan and improves several indicators of healthspan”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as De Haes et al. 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The addition of metformin to the diet can delay aging and increase life span in both C. elegans and rodents (66–68) (see Table 1).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567 · cited 1×
“This contradicts the classic oxidative stress theory of aging, which postulates that ROS, because of their ability to damage biomolecules, would be the causative factor of aging (44).”
BackgroundRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Proc Natl Acad Sci USA 98(14):7863–7868.”
The Nematode Caenorhabditis elegans
Wood, W. B. (1988) · Cold Spring Harbor Laboratory eBooks · Cited by 3,049
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023 · cited 1×
“The physiological response to DR causes lifespan extension and delays age-dependent decline from yeast to primates (8).”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Huang, D. W., Sherman, B. T., Tan, Q., Collins, J. R., Alvord, W. G., Roayaei, J., Stephens, R., Baseler, M. W., Lane, H. C., & Lempicki, R. A. (2007) · Genome Biology · doi:10.1186/gb-2007-8-9-r183 · Cited by 2,479
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Antioxidants prevent health-promoting effects of physical exercise in humans
Ristow, M., Zarse, K., Oberbach, A., Klöting, N., Birringer, M., Kiehntopf, M., Stumvoll, M., Kahn, C. R., & Blüher, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903485106 · Cited by 1,582 · cited 2×
“Proc Natl Acad Sci USA 105(50):19839–19844.”
BackgroundMetformin improves healthspan and lifespan in mice
Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445 · cited 3×
“One of the most striking properties of metformin as an antidiabetic in humans is its ability to cause weight loss in patients through, among others, activation of the β-oxidation pathway (2, 35, 36).”
BackgroundEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans
Herndon, L. A., Schmeissner, P. J., Dudaronek, J. M., Brown, P. A., Listner, K. M., Sakano, Y., Paupard, M. C., Hall, D. H., & Driscoll, M. (2002) · Nature · doi:10.1038/nature01135 · Cited by 1,214
Schulz, T. J., Zarse, K., Voigt, A., Urban, N., Birringer, M., & Ristow, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.011 · Cited by 1,209 · cited 12×
“This increase in ROS seems to be an integral part of metformin-induced lifespan extension, because treatment with the potent antioxidants N-acetylcysteine (NAC) (13) and butylated hydroxyanisole (BHA) (26) abolished the positive effect of metformin on lifespan (Fig.”
BackgroundInfluentialForetz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · cited 1×
“In mammals, metformin is generally believed to act through the activation of AMPK, one of the main regulators of cellular energy homeostasis (2, 14–16), but recent research suggests the existence of AMPK-independent mechanisms as well (17, 18).”
BackgroundRates of Behavior and Aging Specified by Mitochondrial Function During Development
Dillin, A., Hsu, A.-L., Arantes-Oliveira, N., Lehrer-Graiwer, J., Hsin, H., Fraser, A. G., Kamath, R. S., Ahringer, J., & Kenyon, C. (2002) · Science · doi:10.1126/science.1077780 · Cited by 1,121 · cited 1×
“elegans is during larval development (24, 42).”
Interplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080 · cited 2×
“elegans insulin receptor mutants (31, 32), other studies have causally linked BCAAs to the development of insulin resistance, diabetes (33), and neuropathologies (34).”
BackgroundThe Cell Non-Autonomous Nature of Electron Transport Chain-Mediated Longevity
Durieux, J., Wolff, S., & Dillin, A. (2011) · Cell · doi:10.1016/j.cell.2010.12.016 · Cited by 1,059
Mitonuclear protein imbalance as a conserved longevity mechanism
Houtkooper, R. H., Mouchiroud, L., Ryu, D., Moullan, N., Katsyuba, E., Knott, G., Williams, R. W., & Auwerx, J. (2013) · Nature · doi:10.1038/nature12188 · Cited by 1,035 · cited 1×
“We observed many changes in the mitochondrial proteome, which might point toward mitonuclear protein imbalance (41) and an altered mitochondrial metabolism.”
BackgroundMetformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967 · cited 4×
“elegans (6) might similarly depend on an amino acid imbalance that occurs through the lowered production of methionine in metformin-treated bacteria (Fig.”
BackgroundInfluentialA Conserved p38 MAP Kinase Pathway in Caenorhabditis elegans Innate Immunity
Kim, D. H., Feinbaum, R., Alloing, G., Emerson, F. E., Garsin, D. A., Inoue, H., Tanaka-Hino, M., Hisamoto, N., Matsumoto, K., Tan, M.-W., et al. (2002) · Science · doi:10.1126/science.1073759 · Cited by 853 · cited 8×
“These oxidized dimers might activate ASK1’s closest ortholog in C. elegans, the MAP kinase NSY-1, which functions upstream in the same signaling pathway as the MAP kinases SEK-1 and PMK-1 (49).”
BackgroundInfluentialLifespan extension by conditions that inhibit translation in Caenorhabditis elegans
Hansen, M., Taubert, S., Crawford, D., Libina, N., Lee, S., & Kenyon, C. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2006.00267.x · Cited by 803 · cited 1×
“Leucine deprivation has previously been associated with reduced TOR signaling (52), which can in turn prolong lifespan and is required for DR-mediated lifespan extension (53).”
BackgroundAmino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila
Grandison, R. C., Piper, M. D. W., & Partridge, L. (2009) · Nature · doi:10.1038/nature08619 · Cited by 773 · cited 1×
“There is some precedence for this hypothesis: amino acid imbalance has been associated with increased longevity in Drosophila melanogaster (54), among others (55).”
BackgroundMiller, R. A., Buehner, G., Chang, Y., Harper, J. M., Sigler, R., & Smith‐Wheelock, M. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00152.x · Cited by 681 · cited 1×
“There is some precedence for this hypothesis: amino acid imbalance has been associated with increased longevity in Drosophila melanogaster (54), among others (55).”
Onken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671 · cited 6×
“Because of its demonstrated beneficial effect on lifespan in the nematode Caenorhabditis elegans (5, 6) and in the rodents Rattus norvegicus (1) and Mus musculus (2), these models facilitate research into the underlying mode of action.”
BackgroundInfluentialTwo neurons mediate diet-restriction-induced longevity in C. elegans
Bishop, N. A., & Guarente, L. (2007) · Nature · doi:10.1038/nature05904 · Cited by 643
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616 · cited 1×
“In mammals, metformin is generally believed to act through the activation of AMPK, one of the main regulators of cellular energy homeostasis (2, 14–16), but recent research suggests the existence of AMPK-independent mechanisms as well (17, 18).”
BackgroundGreer, E. L., & Brunet, A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00459.x · Cited by 572 · cited 1×
“Int J Biochem Cell Biol 45(12):2749–2755.”
PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans
Panowski, S. H., Wolff, S., Aguilaniu, H., Durieux, J., & Dillin, A. (2007) · Nature · doi:10.1038/nature05837 · Cited by 543
Rattan, S. I. S. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.03.002 · Cited by 498
Typical 2‐Cys peroxiredoxins – structures, mechanisms and functions
Hall, A., Karplus, P. A., & Poole, L. B. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.06985.x · Cited by 465 · cited 1×
“PRDX-2 is a typical 2-Cys peroxiredoxin (45), of which the active, oxidized form exists as a homodimer (48).”
BackgroundYang, K.-S., Kang, S. W., Woo, H. A., Hwang, S. C., Chae, H. Z., Kim, K., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206626200 · Cited by 458 · cited 1×
“Peroxiredoxins are a class of antioxidant proteins characterized by their high susceptibility to cysteine oxidation (46, 47).”
BackgroundInoue, H., Hisamoto, N., An, J. H., Oliveira, R. P., Nishida, E., Blackwell, T. K., & Matsumoto, K. (2005) · Genes & Development · doi:10.1101/gad.1324805 · Cited by 442 · cited 7×
“Active PRDX-2 will activate a conserved MAPK cascade containing the p38 MAPK PMK-1, likely leading to the activation of SKN-1 (28) and a concomitant increase in longevity and stress protection (dashed arrows: literaturebased evidence; Fig.”
BackgroundInfluentialZarse, K., Schmeisser, S., Groth, M., Priebe, S., Beuster, G., Kuhlow, D., Guthke, R., Platzer, M., Kahn, C. R., & Ristow, M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.013 · Cited by 430 · cited 5×
“This increase in ROS seems to be an integral part of metformin-induced lifespan extension, because treatment with the potent antioxidants N-acetylcysteine (NAC) (13) and butylated hydroxyanisole (BHA) (26) abolished the positive effect of metformin on lifespan (Fig.”
BackgroundInfluentialCalorie restriction mimetics: an emerging research field
Ingram, D. K., Zhu, M., Mamczarz, J., Zou, S., Lane, M. A., Roth, G. S., & DeCabo, R. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00202.x · Cited by 415
McElwee, J. J., Schuster, E., Blanc, E., Thomas, J. H., & Gems, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406207200 · Cited by 401 · cited 1×
“coli (57), glp4(bn2ts) daf-16(mgDf50) double mutants were used.”
MethodMetformin slows down aging and extends life span of female SHR mice
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Tyndyk, M. L., Yurova, M. V., Kovalenko, I. G., Poroshina, T. E., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6625 · Cited by 348 · cited 2×
“M an antiglycemic biguanide drug and the most common treatment of type II diabetes mellitus, has lifeextending capabilities (1, 2).”
BackgroundLee, A., & Morley, J. E. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00314.x · Cited by 320 · cited 1×
“One of the most striking properties of metformin as an antidiabetic in humans is its ability to cause weight loss in patients through, among others, activation of the β-oxidation pathway (2, 35, 36).”
BackgroundStephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., & Guigas, B. (2011) · Diabetologia · doi:10.1007/s00125-011-2311-5 · Cited by 287
Leucine Deprivation Increases Hepatic Insulin Sensitivity via GCN2/mTOR/S6K1 and AMPK Pathways
Xiao, F., Huang, Z., Li, H., Yu, J., Wang, C., Chen, S., Meng, Q., Cheng, Y., Gao, X., Li, J., et al. (2011) · Diabetes · doi:10.2337/db10-1246 · Cited by 286 · cited 1×
“Leucine deprivation has previously been associated with reduced TOR signaling (52), which can in turn prolong lifespan and is required for DR-mediated lifespan extension (53).”
BackgroundJarvis, R. M., Hughes, S. M., & Ledgerwood, E. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.001 · Cited by 276 · cited 5×
“These oxidized dimers might activate ASK1’s closest ortholog in C. elegans, the MAP kinase NSY-1, which functions upstream in the same signaling pathway as the MAP kinases SEK-1 and PMK-1 (49).”
BackgroundInfluentialMetformin Activates AMP Kinase through Inhibition of AMP Deaminase
Ouyang, J., Parakhia, R. A., & Ochs, R. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121806 · Cited by 242 · cited 3×
“More upstream, metformin is thought to activate AMPK through partial inhibition of complex I of the electron transport chain (ETC) and a resultant increase in the AMP/ATP ratio (19–21), although again, not all data support this theory (16, 22).”
BackgroundResultMicroRNA Predictors of Longevity in Caenorhabditis elegans
Pincus, Z., Smith-Vikos, T., & Slack, F. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002306 · Cited by 191 · cited 2×
“Although long-lived mutants are often smaller than their wild-type siblings (39), our results fit the recent observations that within isogenic populations the larger animals are generally the longer-lived ones (38).”
BackgroundResultRizos, C. V., & Elisaf, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.02.038 · Cited by 169
Mechanisms responsible for regulation of branched-chain amino acid catabolism
Harris, R. A., Joshi, M., & Ho Jeoung, N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.007 · Cited by 166
Oláhová, M., Taylor, S. R., Khazaipoul, S., Wang, J., Morgan, B. A., Matsumoto, K., Blackwell, T. K., & Veal, E. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805507105 · Cited by 162 · cited 2×
“PRDX-2 is a typical 2-Cys peroxiredoxin (45), of which the active, oxidized form exists as a homodimer (48).”
BackgroundSimone, R. D., Vissicchio, F., Mingarelli, C., Nuccio, C. D., Visentin, S., Ajmone‐Cat, M. A., & Minghetti, L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.001 · Cited by 151 · cited 2×
“elegans insulin receptor mutants (31, 32), other studies have causally linked BCAAs to the development of insulin resistance, diabetes (33), and neuropathologies (34).”
BackgroundA metabolic signature of long life in Caenorhabditis elegans
Fuchs, S., Bundy, J. G., Davies, S. K., Viney, J. M., Swire, J. S., & Leroi, A. M. (2010) · BMC Biology · doi:10.1186/1741-7007-8-14 · Cited by 150 · cited 3×
“elegans insulin receptor mutants (31, 32), other studies have causally linked BCAAs to the development of insulin resistance, diabetes (33), and neuropathologies (34).”
BackgroundAssaying metabolic activity in ageing Caenorhabditis elegans
Braeckman, B. P., Houthoofd, K., Vreese, A. D., & Vanfleteren, J. R. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00331-1 · Cited by 148 · cited 1×
“Metabolic activity and respiration measurements were carried out as previously described (61).”
MethodSelf-citationSchmeisser, S., Priebe, S., Groth, M., Monajembashi, S., Hemmerich, P., Guthke, R., Platzer, M., & Ristow, M. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.02.002 · Cited by 146 · cited 2×
“Metformin has been put forward as a possible DR mimetic (7), and because DR has been linked to mitohormesis (13, 25), we looked into evidence for a role for mitohormesis in metformin-induced lifespan extension.”
BackgroundIdentification of potential caloric restriction mimetics by microarray profiling
Dhahbi, J. M., Mote, P. L., Fahy, G. M., & Spindler, S. R. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00069.2005 · Cited by 122 · cited 1×
“In addition, metformin-treated worms show phenotypes similar to DR worms (5), and transcript profiles of metformin-treated and DR mice also overlap significantly (9).”
BackgroundKarabinos, A., Schmidt, H., Harborth, J., Schnabel, R., & Weber, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121169998 · Cited by 114 · cited 1×
“elegans remains elusive, but the intermediate filament protein IFC-2 (up-regulated after metformin treatment; Dataset S1) seems particularly promising because it is required for normal body shape and cuticle strength (56).”
BackgroundThe Caenorhabditis elegans epidermis as a model skin. II: differentiation and physiological roles
Chisholm, A. D., & Xu, S. (2012) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.77 · Cited by 108 · cited 2×
“Deterioration in cuticle structure leads to a loss in barrier function, which may be one of the causes of death of older nematodes (37, 40).”
BackgroundOta, S., Horigome, K., Ishii, T., Nakai, M., Hayashi, K., Kawamura, T., Kishino, A., Taiji, M., & Kimura, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.164 · Cited by 104 · cited 1×
“Proc Natl Acad Sci USA 106(21):8665–8670.”
Depuydt, G., Xie, F., Petyuk, V. A., Shanmugam, N., Smolders, A., Dhondt, I., Brewer, H. M., Camp, D. G., Smith, R. D., & Braeckman, B. P. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.027383 · Cited by 93 · cited 2×
“elegans insulin receptor mutants (31, 32), other studies have causally linked BCAAs to the development of insulin resistance, diabetes (33), and neuropathologies (34).”
BackgroundSelf-citationMetformin-Treated Patients With Type 2 Diabetes Have Normal Mitochondrial Complex I Respiration
Larsen, S., Rabøl, R., Hansen, C. N., Madsbad, S., Helge, J. W., & Dela, F. (2012) · Diabetologia · doi:10.1007/s00125-011-2340-0 · Cited by 81 · cited 2×
“More upstream, metformin is thought to activate AMPK through partial inhibition of complex I of the electron transport chain (ETC) and a resultant increase in the AMP/ATP ratio (19–21), although again, not all data support this theory (16, 22).”
BackgroundResultBrys, K., Castelein, N., Matthijssens, F., Vanfleteren, J. R., & Braeckman, B. P. (2010) · BMC Biology · doi:10.1186/1741-7007-8-91 · Cited by 74
Self-citationMultidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease
Nakajima, K. (2012) · International Journal of Hepatology · doi:10.1155/2012/950693 · Cited by 46 · cited 2×
“Thamsen M, Kumsta C, Li F, Jakob U (2011) Is overoxidation of peroxiredoxin physiologically significant? Antioxid Redox Signal 14(4):725–730.”
BackgroundProteome changes of Caenorhabditis elegans upon a Staphylococcus aureus infection
Bogaerts, A., Beets, I., Temmerman, L., Schoofs, L., & Verleyen, P. (2010) · Biology Direct · doi:10.1186/1745-6150-5-11 · Cited by 46
Self-citationRotenone induces reductive stress and triacylglycerol deposition in C2C12 cells
He, Q., Wang, M., Petucci, C., Gardell, S. J., & Han, X. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.09.011 · Cited by 44 · cited 1×
“As a case in point, the complex I inhibitor rotenone indeed increases the NADH/NAD ratio (51) and lowers the activity of the β-oxidation pathway (16).”
BackgroundIser, W. B., & Wolkow, C. A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001240 · Cited by 42 · cited 1×
“Although long-lived mutants are often smaller than their wild-type siblings (39), our results fit the recent observations that within isogenic populations the larger animals are generally the longer-lived ones (38).”
ResultMitręga, K. A., Żorniak, M., Varghese, B., Lange, D., Nożyński, J. K., Porc, M., Białka, S., & Krzemiński, T. F. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.04.011 · Cited by 39 · cited 1×
“their effectiveness has been noted in the treatment of liver and cardiac diseases (29, 30), and up-regulation of BCAAs is one of the metabolic signatures of the long-lived daf-2 mutant (31, 32).”
BackgroundIs Overoxidation of Peroxiredoxin Physiologically Significant?
Thamsen, M., Kumsta, C., Li, F., & Jakob, U. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3717 · Cited by 38
Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin
Stachowicz, A., Suski, M., Olszanecki, R., Madej, J., Okoń, K., & Korbut, R. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.08.015 · Cited by 28 · cited 1×
“One of the most striking properties of metformin as an antidiabetic in humans is its ability to cause weight loss in patients through, among others, activation of the β-oxidation pathway (2, 35, 36).”
BackgroundWirth, M., Paap, F., Fischle, W., Wenzel, D., Agafonov, D. E., Samatov, T. R., Wiśniewski, J. R., & Jedrusik, M. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00018-09 · Cited by 26 · cited 1×
“Blots were reincubated with rabbit anti-histone H3 antibodies (Abcam) as a loading control (63).”
MethodRole of branched‐chain amino acids in management of cirrhosis and hepatocellular carcinoma
Lam, V. W.-T., & Poon, R. T. P. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00435.x · Cited by 25 · cited 1×
“their effectiveness has been noted in the treatment of liver and cardiac diseases (29, 30), and up-regulation of BCAAs is one of the metabolic signatures of the long-lived daf-2 mutant (31, 32).”
Background
Research works printed but not linked: 1
- T Stiernagle in The C. elegans Research Community WormBook 10.1895/wormbook.1.101.1. Available at www.wormbook.org/chapters/www_strainmaintain/strainmaintain.html. Accessed December 10 2010. (2006). · DOI · Paper page
Cited by
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
“Also, other investigators have suggested additional mechanisms for metformin actions (De Haes et al., 2014; Onken and Driscoll, 2010) supporting widely pleotropic effects.”
Machine Learning in Drug Discovery: A Review
Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 792
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
Mitochondrial dysfunction in diabetic kidney disease
Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 634
Shields, H. J., Traa, A., & Van Raamsdonk, J. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.628157 · Cited by 478
Metadata
- Authors
- De Haes, W., Frooninckx, L., Van Assche, R., Smolders, A., Depuydt, G., Billen, J., Braeckman, B. P., Schoofs, L., & Temmerman, L.
- Affiliations
- Laboratory for Functional Genomics and Proteomics and
- Ghent University (BE)
- KU Leuven (BE)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-06-02
- Volume
- 111
- Issue
- 24
- Pages
- E2501-9
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4066537
- OpenAlex
- W2058881502
- Cited by
- 355
- References
- 65
- Citations by year
- 2026: 14 · 2025: 33 · 2024: 21 · 2023: 35 · 2022: 32 · 2021: 28 · 2020: 37 · 2019: 39 · 2018: 30 · 2017: 22 · 2016: 31 · 2015: 26 · 2014: 7
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- National Institutes of Health (OD010440, P40OD010440)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- metformin, lifespan extension, mitohormesis, reactive oxygen species, aging, Caenorhabditis elegans, branched-chain amino acid catabolism, type 2 diabetes
- MeSH terms
- Amino Acids, Branched-Chain, Animals, Gene Expression Regulation, Hot Temperature, Hydrogen Peroxide, Hypoglycemic Agents, Longevity, Metformin, Mitochondria, Oxygen Consumption, Rotenone, Time Factors, Signal Transduction, Caenorhabditis elegans, Reactive Oxygen Species, Oxidative Stress, Models, Animal, Caenorhabditis elegans Proteins, Proteomics, Acyl-CoA Dehydrogenase, Green Fluorescent Proteins, Peroxiredoxins, Protein Unfolding, Hormesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.